USP37 and breast carcinoma: As shown in Figure 8D, E, up-regulation of USP37 was detected in 84.5% (93 of 110) of breast cancer tissues, while 82.5% (66 of 80) of adjusted normal breast tissues showed low expression of USP37, confirming that USP37 is overexpressed in human breast cancer samples.